apl. Prof. Dr. Udo Gaipl

Medizinische Fakultät Department of Radiation Oncology

Hypofractionated Radiation increases the Expression of the Immune Checkpoint-Molecule HVEM on TS/A Breast Cancer- and B16 Melanoma Cells (2021) Flohr AS, Grün A, Fietkau R, Rückert M, Gaipl U Conference contribution Detection of Human Cytomegalovirus (HCMV) in monocytic Cells of the peripheral Blood in Glioma Patients during Radio (chemo) Therapy (2021) Bäumler M, Becker I, Frey B, Pohn A, Winkler T, Fietkau R, Gaipl U Conference contribution Low-Dose Radiotherapy is highly effective in the Treatment of painful Finger Polyarthrosis (2021) Weissmann T, Gaipl U, Putz F, Hecht M, Donaubauer AJ, Zhou J, Fietkau R, et al. Conference contribution The Growth of primary and abscopal Tumors as well as their immunological Microenvironment are differently influenced by different Combinations of Radiation and Immunotherapies (2021) Rückert M, Deloch L, Frey B, Fietkau R, Gaipl U Conference contribution Progress Patterns under Radioimmunotherapy - clinical Evaluation of the prospective STICI Study (2021) Schubert P, Schweizer C, Roesch J, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, et al. Conference contribution In Vitro Examinations of Cell Death Induction and the Immune Phenotype of Cancer Cells Following Radiative-Based Hyperthermia with 915 MHz in Combination with Radiotherapy (2021) Hader M, Streit S, Rosin A, Gerdes T, Wadepohl M, Bekeschus S, Fietkau R, et al. Journal article Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. (2021) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution Radiotherapy and the immune system: More than just immune suppression (2021) Rückert M, Flohr AS, Hecht M, Gaipl U Journal article, Review article Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy (2021) Zhou JG, Liang B, Liu JG, Jin SH, He SS, Frey B, Gu N, et al. Journal article Implementation of double immune checkpoint blockade increases response rate to induction chemotherapy in head and neck cancer (2021) Semrau S, Gostian AO, Traxdorf M, Eckstein M, Rutzner S, von der Grün J, Illmer T, et al. Journal article